A multi-cytokine inhibitory peptide (BNZ 132-1) that is a potential therapeutic agent for HAMTSP and other necrotizing diseases.

類似資料

• BNZ-gamma peptide, a potential therapeutic agent in HTLV-1 associated myelopathy
  著者:: Massoud, Raya, 等
  出版事項: (2014)
• Targeting the Binding Interface on a Shared Receptor Subunit of a Cytokine Family Enables the Inhibition of Multiple Member Cytokines with Selectable Target Spectrum
  著者:: Nata, Toshie, 等
  出版事項: (2015)
• Common γ-chain blocking peptide reduces in vitro immune activation markers in HTLV-1-associated myelopathy/tropical spastic paraparesis
  著者:: Massoud, Raya, 等
  出版事項: (2015)
• Results From a First-in-Human Study of BNZ-1, a Selective Multicytokine Inhibitor Targeting Members of the Common Gamma (γ c) Family of Cytokines
  著者:: Frohna, Paul A., 等
  出版事項: (2019)
• IL-2 and IL-15 blockade by BNZ-1, an inhibitor of selective γ-chain cytokines, decreases leukemic T-cell viability
  著者:: Wang, T. Tiffany, 等
  出版事項: (2018)